Terns Pharmaceuticals (TERN)
(Delayed Data from NSDQ)
$5.67 USD
-0.41 (-6.74%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $5.67 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Terns Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
TERN 5.67 -0.41(-6.74%)
Will TERN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TERN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TERN
Down -39.83% in 4 Weeks, Here's Why Terns Pharmaceuticals (TERN) Looks Ripe for a Turnaround
Down -31.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Terns Pharmaceuticals (TERN)
TERN: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About Terns Pharmaceuticals (TERN) Rating Upgrade to Buy
Biotech Stock Roundup: TERN, SMMT Stocks Surge on Study Data, GSK's Vaccine Study Fails & More
Terns Stock Soars on Positive Data From Phase I Study of Obesity Drug
Other News for TERN
Terns Pharma (TERN) Projects Financial Stability Until 2028 with Ongoing Trials
Terns Pharmaceuticals GAAP EPS of -$0.26 beats by $0.03
Terns Pharmaceuticals reports Q2 EPS (26c), consensus (29c)
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule ...
Commit To Buy Terns Pharmaceuticals At $3, Earn 23.3% Using Options